Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
bioAffinity Technologies Appoints Three New Medical and Scientific Advisory Board Members
bioAffinity Technologies has expanded its Medical and Scientific Advisory Board with the appointment of three new members: Drs. David Ost, Daniel Sterman, and J. Scott Ferguson. These appointments aim to align the board with the company’s clinical, scientific, and commercial priorities, particularly for its noninvasive lung cancer diagnostic test, CyPath Lung. The new members are highly respected leaders in pulmonary medicine and lung cancer care, and their expertise will support the integration and adoption of CyPath Lung for early lung cancer detection.